Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 16, 2018
Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786)E Vigneault, G Morton, W R Parulekar, et al.
Journal of Translational Medicine|May 25, 2019
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomyC Hoey, M Ahmed, A Fotouhi Ghiam, et al.
British Journal of Cancer|November 1, 2007
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerR K Nam, L Sugar, W Yang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2019
Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patientsK Martell, L C Mendez, H T Chung, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 27, 2016
Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian DataA Loblaw, T Pickles, J Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 4, 2024
Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells - Implications for systemic controlH Wang, L Mendez, G Morton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancerK Martell, L C Mendez, H Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2001
Prospective patient-based assessment of effectiveness of palliative radiotherapy for bone metastasesE Chow, R Wong, G Hruby, et al.
Prostate Cancer and Prostatic Diseases|September 19, 2007
A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancerR K Nam, W W Zhang, D A Loblaw, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 26, 2019
Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective TrialsS Roy, A Loblaw, P Cheung, et al.
Pageof 5